Shopping Cart 0
Cart Subtotal
USD 0

Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 8000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 12000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Transcatheter Heart Valves-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Transcatheter Heart Valves-Medical Devices Pipeline Assessment, 2018 provides an overview of Transcatheter Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Transcatheter Heart Valves under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Transcatheter Heart Valves and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Transcatheter Heart Valves under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 16

2 Introduction 17

2.1 Transcatheter Heart Valves Overview 17

3 Products under Development 18

3.1 Transcatheter Heart Valves-Pipeline Products by Stage of Development 18

3.2 Transcatheter Heart Valves-Pipeline Products by Segment 19

3.3 Transcatheter Heart Valves-Pipeline Products by Territory 20

3.4 Transcatheter Heart Valves-Pipeline Products by Regulatory Path 22

3.5 Transcatheter Heart Valves-Pipeline Products by Estimated Approval Date 23

3.6 Transcatheter Heart Valves-Ongoing Clinical Trials 24

4 Transcatheter Heart Valves-Pipeline Products under Development by Companies 25

4.1 Transcatheter Heart Valves Companies-Pipeline Products by Stage of Development 25

4.2 Transcatheter Heart Valves-Pipeline Products by Stage of Development 28

5 Transcatheter Heart Valves Companies and Product Overview 32

5.1 4C Medical Technologies Inc Company Overview 32

5.2 Admedus Ltd Company Overview 33

5.3 Aegis Surgical Limited Company Overview 34

5.4 Annulon Company Overview 35

5.5 AorTech International Plc Company Overview 36

5.6 AorTx, Inc. Company Overview 37

5.7 Arbor Surgical Technologies, Inc. Company Overview 38

5.8 Boston Children's Hospital Company Overview 39

5.9 Boston Scientific Corp Company Overview 40

5.10 Carena Healthcare Ltd Company Overview 63

5.11 Cephea Valve Technologies, Inc. Company Overview 64

5.12 Children's Hospital Boston Company Overview 65

5.13 Clemson University Company Overview 66

5.14 Colibri Heart Valve, LLC Company Overview 67

5.15 Daidalos Solutions BV Company Overview 74

5.16 Direct Flow Medical Inc (Inactive) Company Overview 76

5.17 DSM Dyneema BV Company Overview 80

5.18 Dura LLC Company Overview 81

5.19 Edwards Lifesciences Corp Company Overview 83

5.20 Emory University Company Overview 102

5.21 Endoluminal Technology Research, LLC Company Overview 103

5.22 Florida International University Company Overview 105

5.23 HighLife SAS Company Overview 106

5.24 HLT, Inc. Company Overview 109

5.25 JC Medical, Inc. Company Overview 112

5.26 JenaValve Technology GmbH Company Overview 117

5.27 LivaNova PLC Company Overview 120

5.28 Mayo Clinic Company Overview 123

5.29 Medtronic plc Company Overview 124

5.30 Meril Life Sciences Pvt Ltd Company Overview 137

5.31 Micro Interventional Devices, Inc. Company Overview 138

5.32 MicroPort Scientific Corp Company Overview 139

5.33 Mitralix Ltd. Company Overview 142

5.34 MitrAssist Ltd. Company Overview 143

5.35 MValve Technologies Ltd. Company Overview 144

5.36 NaviGate Cardiac Structures, Inc. Company Overview 147

5.37 Neovasc Inc Company Overview 151

5.38 PolyNova Cardiovascular LLC (Inactive) Company Overview 154

5.39 Polyvascular Corp Company Overview 155

5.40 RegenaGraft Company Overview 156

5.41 ReValve Med Inc Company Overview 157

5.42 SAS Cormove Company Overview 158

5.43 Sino Medical Sciences Technology Inc Company Overview 159

5.44 St. Jude Medical LLC Company Overview 160

5.45 Symetis SA Company Overview 164

5.46 Thubrikar Aortic Valve, Inc. Company Overview 175

5.47 Trinity College Dublin Company Overview 176

5.48 University College London Company Overview 177

5.49 University of California San Francisco Company Overview 179

5.50 University of Cambridge Company Overview 180

5.51 University of Iowa Company Overview 181

5.52 Valtech Cardio Ltd Company Overview 183

5.53 Vascular Concepts Ltd Company Overview 186

5.54 Venus MedTech Company Overview 187

5.55 Xeltis AG Company Overview 194

6 Transcatheter Heart Valves- Recent Developments 195

6.1 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 195

6.2 May 31, 2018: JC Medical Announces First-in-Human Treatment with the Unique Transfemoral J-Valve TAVI Device for Aortic Regurgitation 195

6.3 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 196

6.4 May 22, 2018: Treatment with Abbott s Portico Transcatheter Aortic Valve Showed Portico is Safe and Reduces Severe Aortic Stenosis at 30 Days in Real-World Setting 198

6.5 May 22, 2018: Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve 200

6.6 May 22, 2018: Admedus: TAVR Progress Continues With Filing of New Provisional Patents 200

6.7 May 21, 2018: Edwards Announces Key Events For EuroPCR 2018 201

6.8 May 21, 2018: NaviGate Cardiac Structures reports excellent valvular function at 1-year follow-up of first patient to receive GATE tricuspid valved stent via transjugular access 202

6.9 May 17, 2018: MicroPort CardioFlow Releases One-year Clinical Outcome of VitaFlow 204

6.10 May 17, 2018: MicroPort CardioFlow Attends Fourth China Valve (Hangzhou) Meeting 204

6.11 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 205

6.12 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018 205

6.13 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018 206

6.14 May 10, 2018: Neovasc Announces Results for the First Quarter 2018 207

6.15 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 211

6.16 May 04, 2018: Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System 211

6.17 Apr 26, 2018: Two-Year Feasibility Study Results Encouraging with Medtronic Harmony Transcatheter Pulmonary Valve 212

6.18 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 213

6.19 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 215

6.20 Apr 19, 2018: Admedus TAVR Gaining Momentum With New Patent Applications 216

6.21 Apr 10, 2018: Jena Valve Technology Continues CE Mark Study Treating Severe Aortic Stenosis with Next-Generation System; Patient Enrollment and Successful Implantations with the Everdur Pericardial Aortic Valve and Coronatix Delivery Catheter 217

6.22 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 218

6.23 Mar 28, 2018: Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation 219

6.24 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 219

6.25 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 223

6.26 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 225

6.27 Mar 23, 2018: Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid 225

6.28 Mar 23, 2018: JenaValve Technology Appoints Keith D Dawkins MD as Board Member 225

6.29 Mar 19, 2018: Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study 226

6.30 Mar 12, 2018: Admedus TAVR Project Passes Testing Milestone 227

6.31 Mar 10, 2018: Clinical Trials Show Strong Long-Term Performance with the Medtronic CoreValve TAVR System 228

6.32 Mar 07, 2018: 4C Medical's Transcatheter Mitral Valve Technology Receives First Place in Cardiovascular Research Technologies 2018 Competition 229

6.33 Mar 01, 2018: 4C Medical's Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2018 Meeting 230

6.34 Feb 28, 2018: First Oregonian receives artificial mitral heart valve without open-heart surgery 230

6.35 Feb 21, 2018: NaviGate Cardiac Structures reports GATE bioprosthesis as the first transcatheter valve replacement in Canada to treat tricuspid regurgitation 231

6.36 Feb 15, 2018: Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark 232

6.37 Feb 08, 2018: First Canadian Medicine: a 10th Case of Tricuspid Replacement Percutaneous in the World Achieved at the Institute 233

6.38 Feb 07, 2018: Polyvascular Aims To Manufacture Tiny Valves For Heart Valve Replacement 233

6.39 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 235

6.40 Feb 02, 2018: JenaValve Technology Appoints Laura A Brenton as Vice President of Clinical and International Market Development 236

6.41 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 236

6.42 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 238

6.43 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 240

6.44 Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer 240

6.45 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 241

6.46 Jan 08, 2018: MicroPort CardioFlow Attends 2017 PCR-CIT China Chengdu Valves 242

6.47 Jan 08, 2018: Neovasc Reports Tiara's Clinical Case Load Accelerating 243

7 Appendix 303

7.1 Methodology 303

7.2 About GlobalData 306

7.3 Contact Us 306

7.4 Disclaimer 306


List Of Figure

1.2 List of Figures

Figure 1: Transcatheter Heart Valves-Pipeline Products by Stage of Development 19

Figure 2: Transcatheter Heart Valves-Pipeline Products by Segment 20

Figure 3: Transcatheter Heart Valves-Pipeline Products by Territory 21

Figure 4: Transcatheter Heart Valves-Pipeline Products by Regulatory Path 23

Figure 5: Transcatheter Heart Valves-Pipeline Products by Estimated Approval Date 24

Figure 6: Transcatheter Heart Valves-Ongoing Clinical Trials 25


List Of Table

1.1 List of Tables

Table 1: Transcatheter Heart Valves-Pipeline Products by Stage of Development 19

Table 2: Transcatheter Heart Valves-Pipeline Products by Segment 20

Table 3: Transcatheter Heart Valves-Pipeline Products by Territory 21

Table 4: Transcatheter Heart Valves-Pipeline Products by Regulatory Path 23

Table 5: Transcatheter Heart Valves-Pipeline Products by Estimated Approval Date 24

Table 6: Transcatheter Heart Valves-Ongoing Clinical Trials 25

Table 7: Transcatheter Heart Valves Companies-Pipeline Products by Stage of Development 26

Table 8: Transcatheter Heart Valves-Pipeline Products by Stage of Development 29

Table 9: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 10: AltaValve-Product Status 33

Table 11: AltaValve-Product Description 33

Table 12: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

Table 13: Transcatheter Aortic Valve Replacement Device-Product Status 34

Table 14: Transcatheter Aortic Valve Replacement Device-Product Description 34

Table 15: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 35

Table 16: pTAo-TAVR-Product Status 35

Table 17: pTAo-TAVR-Product Description 35

Table 18: Annulon Pipeline Products & Ongoing Clinical Trials Overview 36

Table 19: Mitral Valve Replacement Device-Product Status 36

Table 20: Mitral Valve Replacement Device-Product Description 36

Table 21: AorTech International Plc Pipeline Products & Ongoing Clinical Trials Overview 37

Table 22: AorTech Polymer Valve-Product Status 37

Table 23: AorTech Polymer Valve-Product Description 37

Table 24: AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 25: AorTx Valve-Product Status 38

Table 26: AorTx Valve-Product Description 38

Table 27: Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39

Table 28: Trilogy Aortic Valve System-Product Status 39

Table 29: Trilogy Aortic Valve System-Product Description 39

Table 30: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 40

Table 31: Pulmonary Valve Replacement Device-Product Status 40

Table 32: Pulmonary Valve Replacement Device-Product Description 40

Table 33: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 41

Table 34: ACURATE TAVR-Product Status 41

Table 35: ACURATE TAVR-Product Description 42

Table 36: Gen 4 Lotus Valve System-Product Status 42

Table 37: Gen 4 Lotus Valve System-Product Description 42

Table 38: Lotus Edge Sheath 15F-Product Status 42

Table 39: Lotus Edge Sheath 15F-Product Description 43

Table 40: Lotus Edge Valve System-21 mm-Product Status 43

Table 41: Lotus Edge Valve System-21 mm-Product Description 43

Table 42: Lotus Edge Valve System-23 mm-Product Status 44

Table 43: Lotus Edge Valve System-23 mm-Product Description 44

Table 44: Lotus Edge Valve System-25 mm-Product Status 44

Table 45: Lotus Edge Valve System-25 mm-Product Description 45

Table 46: Lotus Edge Valve System-27 mm-Product Status 45

Table 47: Lotus Edge Valve System-27 mm-Product Description 45

Table 48: Lotus Edge Valve System-29 mm-Product Status 46

Table 49: Lotus Edge Valve System-29 mm-Product Description 46

Table 50: Lotus Valve System-21 mm-Product Status 46

Table 51: Lotus Valve System-21 mm-Product Description 47

Table 52: Lotus Valve System-23 mm-Product Status 47

Table 53: Lotus Valve System-23 mm-Product Description 48

Table 54: Lotus Valve System-25 mm-Product Status 48

Table 55: Lotus Valve System-25 mm-Product Description 49

Table 56: Lotus Valve System-27 mm-Product Status 49

Table 57: Lotus Valve System-27 mm-Product Description 49

Table 58: Lotus Valve System-29 mm-Product Status 50

Table 59: Lotus Valve System-29 mm-Product Description 50

Table 60: Transaortic Sheath-Product Status 50

Table 61: Transaortic Sheath-Product Description 51

Table 62: Boston Scientific Corp-Ongoing Clinical Trials Overview 52

Table 63: Lotus Valve System-23 mm-Experience with Percutaneous Transcatheter Aortic Valve Implantation in Patients with Symptomatic Aortic Valve Disease in Two German Centers 54

Table 64: Lotus Valve System-23 mm-Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve 54

Table 65: Lotus Valve System-23 mm-Re-positionable Lotus Valve System-Post Market Evaluation of Real World Clinical Outcomes: RESPOND 54

Table 66: Lotus Valve System-23 mm-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System-Clinical Evaluation in China: REPRISE China 55

Table 67: Lotus Valve System-23 mm-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System-Clinical Evaluation in Japan: REPRISE Japan 55

Table 68: Lotus Valve System-23 mm-Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA) 55

Table 69: Lotus Valve System-27 mm-Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve 56

Table 70: Lotus Valve System-27 mm-Re-positionable Lotus Valve System-Post Market Evaluation of Real World Clinical Outcomes: RESPOND 56

Table 71: Lotus Valve System-27 mm-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System-Clinical Evaluation in China: REPRISE China 56

Table 72: Lotus Valve System-27 mm-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System-Clinical Evaluation in Japan: REPRISE Japan 57

Table 73: Lotus Valve System-27 mm-Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA) 57

Table 74: Lotus Valve System-25 mm-Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve 58

Table 75: Lotus Valve System-25 mm-Re-positionable Lotus Valve System-Post Market Evaluation of Real World Clinical Outcomes: RESPOND 58

Table 76: Lotus Valve System-25 mm-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System-Clinical Evaluation in China: REPRISE China 58

Table 77: Lotus Valve System-25 mm-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System-Clinical Evaluation in Japan: REPRISE Japan 59

Table 78: Lotus Valve System-25 mm-Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA) 59

Table 79: Lotus Valve System-21 mm-Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve 60

Table 80: Lotus Valve System-21 mm-Re-positionable Lotus Valve System-Post Market Evaluation of Real World Clinical Outcomes: RESPOND 60

Table 81: Lotus Valve System-21 mm-Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA) 60

Table 82: Lotus Valve System-29 mm-Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve 61

Table 83: Lotus Valve System-29 mm-Re-positionable Lotus Valve System-Post Market Evaluation of Real World Clinical Outcomes: RESPOND 61

Table 84: Lotus Valve System-29 mm-Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA) 61

Table 85: Lotus Edge Valve System-23 mm-Randomized Comparison of Repositionable and Balloon-Expandable Prostheses in Patients Undergoing Trans-catheter Aortic Valve Implantation 62

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

4C Medical Technologies Inc, AltaValve; Admedus Ltd, Transcatheter Aortic Valve Replacement Device; Aegis Surgical Limited, pTAo-TAVR; Annulon, Mitral Valve Replacement Device; AorTech International Plc, AorTech Polymer Valve; AorTx, Inc., AorTx Valve; Arbor Surgical Technologies, Inc., Trilogy Aortic Valve System; Boston Children's Hospital, Pulmonary Valve Replacement Device; Boston Scientific Corp, ACURATE TAVR; Boston Scientific Corp, Gen 4 Lotus Valve System; Boston Scientific Corp, Lotus Edge Sheath 15F; Boston Scientific Corp, Lotus Edge Valve System - 21 mm; Boston Scientific Corp, Lotus Edge Valve System - 23 mm; Boston Scientific Corp, Lotus Edge Valve System - 25 mm; Boston Scientific Corp, Lotus Edge Valve System - 27 mm; Boston Scientific Corp, Lotus Edge Valve System - 29 mm; Boston Scientific Corp, Lotus Valve System - 21 mm; Boston Scientific Corp, Lotus Valve System - 23 mm; Boston Scientific Corp, Lotus Valve System - 25 mm; Boston Scientific Corp, Lotus Valve System - 27 mm; Boston Scientific Corp, Lotus Valve System - 29 mm; Boston Scientific Corp, Transaortic Sheath; Carena Healthcare Ltd, PILLAR 3D Printed Replacement Heart Valve; Cephea Valve Technologies, Inc., Mitral Valve Replacement Device; Children's Hospital Boston, Two Piece Replacement Heart Valve; Clemson University, Transcatheter Bioprosthetic Heart Valve; Colibri Heart Valve, LLC, Colibri Aortic Heart Valve - 24mm; Colibri Heart Valve, LLC, Colibri Aortic Heart Valve - 21mm; Colibri Heart Valve, LLC, Colibri Aortic Heart Valve - 27mm; Colibri Heart Valve, LLC, Colibri TAVI System; Colibri Heart Valve, LLC, Delta Aortic Heart Valve; Colibri Heart Valve, LLC, Mitral Valve; Colibri Heart Valve, LLC, Venibri Transcatheter Heart Valve System; Daidalos Solutions BV, Sutureless Trans-Catheter Aortic Valve Replacement (TAVR); Daidalos Solutions BV, Sutureless Trans-Catheter Mitral Valve Replacement (TMVR); Daidalos Solutions BV, Sutureless Trans-Catheter Tricuspid Valve Replacement (TTVR); Direct Flow Medical Inc (Inactive), 18F Direct Flow Medical Transcatheter Aortic Valve System; Direct Flow Medical Inc (Inactive), 22F Percutaneous Aortic Valve System; Direct Flow Medical Inc (Inactive), Direct Flow Medical Transcatheter Mitral Valve; DSM Dyneema BV, Dyneema Purity - Transcatheter Heart Valve; Dura LLC, LowPro Valve; Dura LLC, Transcatheter Pulmonary Valve Device; Edwards Lifesciences Corp, Cardiaq Mitral Valve; Edwards Lifesciences Corp, Edwards CENTERA Valve; Edwards Lifesciences Corp, Edwards SAPIEN 3 Transcatheter Heart Valve - Low Risk; Edwards Lifesciences Corp, FORTIS Mitral Transcatheter Heart Valve; Edwards Lifesciences Corp, Next Gen CENTERA; Edwards Lifesciences Corp, Next Gen SAPIEN; Edwards Lifesciences Corp, PASCAL Transcatheter Mitral Valve Repair System; Edwards Lifesciences Corp, Sapien 3 Heart Valve - Heart Failure; Edwards Lifesciences Corp, Sapien 3 Heart Valve - Mitral Annular Calcification; Edwards Lifesciences Corp, Sapien 3 Heart Valve - Pulmonic; Edwards Lifesciences Corp, Sapien Evolutionary Transcatheter Heart Valve; Edwards Lifesciences Corp, SAPIEN M3; Edwards Lifesciences Corp, Sapien Revolutionary Transcatheter Heart Valve; Edwards Lifesciences Corp, Second Generation Transapical Transcatheter Mitral Valve; Emory University, MitraCath; Endoluminal Technology Research, LLC, Balloon Expandable Paniagua Heart Valve; Endoluminal Technology Research, LLC, Self Expandable Paniagua Heart Valve; Florida International University, Percutaneous Aortic Heart Valve; HighLife SAS, Transcatheter Mitral Valve Replacement System; HLT, Inc., HLT Transcatheter Valve System; JC Medical, Inc., J-Valve TAVI System - Transapical; JC Medical, Inc., J-Valve TAVI System - Transfemoral; JenaValve Technology GmbH, JenaValve Pericardial TAVR System; LivaNova PLC , Caisson TMVR System; Mayo Clinic, Percutaneous Aortic Valve; Medtronic plc, CoreValve Evolut PRO - 34 mm; Medtronic plc, CoreValve Evolut R Recapturable System - Low-Risk Aortic Stenosis; Medtronic plc, Harmony Transcatheter Pulmonary Valve; Medtronic plc, Intrepid Transcatheter Mitral Valve Replacement; Medtronic plc, Native Outflow Tract Transcatheter Pulmonary Valve; Medtronic plc, Next Generation TCV; Medtronic plc, TCV - Aortic; Medtronic plc, TCV - Mitral; Medtronic plc, TCV - Pulmonic; Medtronic plc, Twelve Transcatheter Mitral Valve Replacement System; Meril Life Sciences Pvt Ltd, Myval Transcatheter Aortic Valve Replacement System; Micro Interventional Devices, Inc., Endovalve; MicroPort Scientific Corp, Vitaflow Transcatheter Aortic Valve; Mitralix Ltd., MAESTRO; MitrAssist Ltd., MitrAssist Valve; MValve Technologies Ltd., MValve Docking System; NaviGate Cardiac Structures, Inc., Gate Tricuspid Valved Stent; NaviGate Cardiac Structures, Inc., Navi Mitral Valved Stent; Neovasc Inc, Tiara Transcatheter Mitral Valve; PolyNova Cardiovascular LLC (Inactive), Trileaflet Polymeric Prosthetic Heart Valve; Polyvascular Corp, Pediatric Valve Device; RegenaGraft, Synthetic Heart Valve; ReValve Med Inc, Removable Transcatheter Aortic Valve; SAS Cormove, CORMOVE Percutaneous Aortic Valve; Sino Medical Sciences Technology Inc, AccuFit Transapical Mitral Valve Replacement Device; St. Jude Medical LLC, Next Generation - Portico Valve; St. Jude Medical LLC, Portico Transcatheter Aortic Valve Implantation System; Symetis SA, ACURATE - Size Matrix Expansion; Symetis SA, ACURATE neo Aortic Bioprosthesis; Symetis SA, ACURATE neo AS Aortic Bioprosthesis - Transfemoral Delivery; Symetis SA, ACURATE TAo; Symetis SA, Acurate TF; Thubrikar Aortic Valve, Inc., Optimum TAVI System; Trinity College Dublin, MiVaR Device; University College London, Percutaneous Mitral Valve Device; University College London, TRISKELE Aortic Valve; University of California San Francisco, Transcatheter Aortic Valve; University of Cambridge, Removable Transcatheter Valve; University of Iowa, Cellulose Based Aortic Heart Valve; University of Iowa, Expandable Transcatheter Flutter Valve; Valtech Cardio Ltd, Valtech Cardiovalve; Vascular Concepts Ltd, TAVI (Transcatheter Aortic Valve Replacement); Venus MedTech, Transapical Trinity Aortic Valve Implantation System; Venus MedTech, Transfemoral Trinity Aortic Valve Implantation System; Venus MedTech, Tresillo System; Venus MedTech, Venus A-Valve; Venus MedTech, Venus P-Valve; Xeltis AG, Transcatheter Aortic Heart Valve


Companies

4C Medical Technologies Inc

Admedus Ltd

Aegis Surgical Limited

Annulon

AorTech International Plc

AorTx, Inc.

Arbor Surgical Technologies, Inc.

Boston Children's Hospital

Boston Scientific Corp

Carena Healthcare Ltd

Cephea Valve Technologies, Inc.

Children's Hospital Boston

Clemson University

Colibri Heart Valve, LLC

Daidalos Solutions BV

Direct Flow Medical Inc

DSM Dyneema BV

Dura LLC

Edwards Lifesciences Corp

Emory University

Endoluminal Technology Research, LLC

Florida International University

HighLife SAS

HLT, Inc.

JC Medical, Inc.

JenaValve Technology GmbH

LivaNova PLC

Mayo Clinic

Medtronic plc

Meril Life Sciences Pvt Ltd

Micro Interventional Devices, Inc.

MicroPort Scientific Corp

Mitralix Ltd.

MitrAssist Ltd.

MValve Technologies Ltd.

NaviGate Cardiac Structures, Inc.

Neovasc Inc

PolyNova Cardiovascular LLC

Polyvascular Corp

RegenaGraft

ReValve Med Inc

SAS Cormove

Sino Medical Sciences Technology Inc

St. Jude Medical LLC

Symetis SA

Thubrikar Aortic Valve, Inc.

Trinity College Dublin

University College London

University of California San Francisco

University of Cambridge

University of Iowa

Valtech Cardio Ltd

Vascular Concepts Ltd

Venus MedTech

Xeltis AG